UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

p53 isoforms can regulate p53 transcriptional activity

Genes & development, 2005-09, Vol.19 (18), p.2122-2137

2005

Link zum Volltext

Verfügbarkeit prüfen

Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53

The Journal of biological chemistry, 2009-02, Vol.284 (8), p.5030-5041

2009

Link zum Volltext

Verfügbarkeit prüfen

Suppression of mutant Kirsten-RAS (KRAS G12D )-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6

Oncogene, 2022-05, Vol.41 (20), p.2811-2823

2022

Link zum Volltext

Verfügbarkeit prüfen

Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity

Cell, 2004-07, Vol.118 (1), p.83-97

2004

Link zum Volltext

Verfügbarkeit prüfen

Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity

Oncotarget, 2018-04, Vol.9 (29), p.20265-20281

2018

Link zum Volltext

Verfügbarkeit prüfen

Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2

FEBS letters, 2022-11, Vol.596 (21), p.2746-2767

2022

Link zum Volltext

Verfügbarkeit prüfen

Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo

The Journal of biological chemistry, 2004-10, Vol.279 (40), p.42169-42181

2004

Link zum Volltext

Verfügbarkeit prüfen

Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

EMBO reports, 2001-11, Vol.2 (11), p.1029-1034

2001

Link zum Volltext

Verfügbarkeit prüfen

The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2

The EMBO journal, 2007-02, Vol.26 (4), p.976-986

2007

Link zum Volltext

Verfügbarkeit prüfen

The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma

Journal of investigative dermatology, 2020-06, Vol.140 (6), p.1154-1165.e5

2020

Link zum Volltext

Verfügbarkeit prüfen

p14 Arf Promotes Small Ubiquitin-like Modifier Conjugation of Werners Helicase

The Journal of biological chemistry, 2004-11, Vol.279 (48), p.50157-50166

2004

Link zum Volltext

Verfügbarkeit prüfen

Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy

Seminars in cancer biology, 2010-02, Vol.20 (1), p.29-39

2010

Link zum Volltext

Verfügbarkeit prüfen

Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules

The EMBO journal, 2006-04, Vol.25 (8), p.1635-1645

2006

Link zum Volltext

Verfügbarkeit prüfen

Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity

Oncotarget, 2018-05, Vol.9 (33), p.23029-23046

2018

Link zum Volltext

Verfügbarkeit prüfen

Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo

Oncogene, 2001-08, Vol.20 (36), p.4972-4983

2001

Link zum Volltext

Verfügbarkeit prüfen

The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties

Oncogene, 1998-11, Vol.17 (21), p.2679-2689

1998

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator

Oncogene, 2001-06, Vol.20 (26), p.3376-3386

2001

Link zum Volltext

Verfügbarkeit prüfen

B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107

Oncogene, 2002-11, Vol.21 (52), p.7923-7932

2002

Link zum Volltext

Verfügbarkeit prüfen

Targeting the ubiquitina"proteasome system to activate wild-type p53 for cancer therapy

Seminars in cancer biology, 2010-02, Vol.20 (1), p.29-39

2010

Link zum Volltext

Verfügbarkeit prüfen

B-Myb: A Key Regulator of the Cell Cycle

Advances in Cancer Research, 1997, Vol.72, p.109-140

1997

Link zum Volltext

Verfügbarkeit prüfen

Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53S

The Journal of biological chemistry, 2008-12, Vol.284 (8), p.5030-5041

2008

Link zum Volltext

Verfügbarkeit prüfen

Regulation of the Cell Cycle by B-Myb

Blood cells, molecules, & diseases, 2001-03, Vol.27 (2), p.416-421

2001

Link zum Volltext

Verfügbarkeit prüfen

An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo

Oncogene, 2000-05, Vol.19 (19), p.2312-2323

2000

Link zum Volltext

Verfügbarkeit prüfen

An N-terminal p14ARFpeptide blocks Mdm2-dependent ubiquitination in vitroand can activate p53 in vivo

Oncogene, 2000-05, Vol.19 (19), p.2312

2000

Link zum Volltext

Verfügbarkeit prüfen

Differential expression of carnosine, homocarnosine and N-acetyl-L-histidine hydrolytic activities in cultured rat macroglial cells

Journal of molecular neuroscience, 2001-12, Vol.17 (3), p.351-360

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(44)
Buchkapitel
(1)

Sprache

Englisch
(45)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(32)
Humans
(26)
Biochemistry & Molecular Biology
(16)
Cell Biology
(15)
Animals
(10)
Biological And Medical Sciences
(10)
Female
(10)
Tumor Suppressor Protein P53 - Metabolism
(10)
Oncology
(8)
Ubiquitin - Metabolism
(7)
Cell Cycle
(6)
Cell Line, Tumor
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Genetics & Heredity
(6)
Male
(6)
Proto-Oncogene Proteins - Metabolism
(6)
Transfection
(6)
Tumor Suppressor Protein P53 - Genetics
(6)
Adult
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

p53 isoforms can regulate p53 transcriptional activity

Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53

Suppression of mutant Kirsten-RAS (KRAS G12D )-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6

Mdm2-Mediated NEDD8 Conjugation of p53 Inhibits Its Transcriptional Activity

Preclinical comparison of proteasome and ubiquitin E1 enzyme inhibitors in cutaneous squamous cell carcinoma: the identification of mechanisms of differential sensitivity

Ubiquitin receptors play redundant roles in the proteasomal degradation of the p53 repressor MDM2

Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo

Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms

The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2

The Identification of Potential Therapeutic Targets for Cutaneous Squamous Cell Carcinoma

p14 Arf Promotes Small Ubiquitin-like Modifier Conjugation of Werners Helicase

Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy

Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules

Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity

Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo

The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties

Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator

B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107

Targeting the ubiquitina"proteasome system to activate wild-type p53 for cancer therapy

B-Myb: A Key Regulator of the Cell Cycle

Suppression of the Deubiquitinating Enzyme USP5 Causes the Accumulation of Unanchored Polyubiquitin and the Activation of p53S

Regulation of the Cell Cycle by B-Myb

An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo

An N-terminal p14ARFpeptide blocks Mdm2-dependent ubiquitination in vitroand can activate p53 in vivo

Differential expression of carnosine, homocarnosine and N-acetyl-L-histidine hydrolytic activities in cultured rat macroglial cells

Suchergebnisse filtern